Patents by Inventor Stella M. Robertson

Stella M. Robertson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5271939
    Abstract: Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
    Type: Grant
    Filed: April 10, 1992
    Date of Patent: December 21, 1993
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr.
  • Patent number: 5192780
    Abstract: Compositions of an antiallergic compound and an antihistamine for preventing and treating ophthalmic allergic responses are disclosed. Methods for preventing and treating ophthalmic allergic responses with the compositions are also disclosed.
    Type: Grant
    Filed: July 23, 1991
    Date of Patent: March 9, 1993
    Assignee: Alcon Laboratories, Inc.
    Inventors: Billie M. York, Stella M. Robertson, John M. Yanni
  • Patent number: 5124392
    Abstract: Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
    Type: Grant
    Filed: May 31, 1990
    Date of Patent: June 23, 1992
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr.
  • Patent number: 4939135
    Abstract: Methods for preventing and treating corneal haze resulting from exposure of the eye to laser irradiation are disclosed. The methods include administration of compositions of wound healing modulators to the eye. Compositions for use in preventing and treating the corneal haze are also disclosed.
    Type: Grant
    Filed: October 3, 1988
    Date of Patent: July 3, 1990
    Assignee: Alcon Laboratories, Inc.
    Inventors: Stella M. Robertson, Herman M. Kunkle, Jr., Michael E. Stern
  • Patent number: 4455296
    Abstract: Continuous hybrid cell lines for producing monoclonal antibodies directed against outer membrane antigens of Haemophilus influenzae type b have been developed. The hybrid cell lines were established by fusing differentiated lymphoid cells primed with outer membrane antigens of Haemophilus influenzae type b with hybridoma cells. The resulting fused cells were cloned and characterized as to antibody specificity against antigenic determinants of outer membranes of Haemophilus influenzae type b. One hybrid produces a monoclonal antibody which is capable of conferring passive immunity on Hib infected hosts.
    Type: Grant
    Filed: February 2, 1982
    Date of Patent: June 19, 1984
    Assignee: Board of Regents, the University of Texas System
    Inventors: Eric J. Hansen, John R. Kettman, Stella M. Robertson